ChitogenX Inc.
CHGX
Rang in aandelen
#39856
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and... ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Aandeelprijs
$0.00365786
Laatst gesynchroniseerd: 2025-07-07
Marktkapitalisatie
$293.82K
Verandering (1 dag)
-0.43%
Verandering (1 jaar)
-28.28%
Land
CA
Handel ChitogenX Inc. (CHGX)
Categorie
Healthcare
Koersgeschiedenis voor ChitogenX Inc. (CHGX)
Hoogste slotkoers: $0.01 op 2026-10-01
Laagste slotkoers: $0.46 op 2020-10-01
Laagste slotkoers: $0.46 op 2020-10-01
Koersgeschiedenis van ChitogenX Inc. van 2020 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -53.93% |
| 2024 | -85.54% |
| 2023 | -64.19% |
| 2022 | -43.64% |
| 2021 | -43.08% |
| 2020 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $530.66 | 24.44% |
US
|
|
| $230.18 | 757.28% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.66 | 9.40% |
NL
|
|
| $290.41 | 2.03% |
BE
|
